全文获取类型
收费全文 | 12345篇 |
免费 | 1269篇 |
国内免费 | 130篇 |
专业分类
耳鼻咽喉 | 95篇 |
儿科学 | 361篇 |
妇产科学 | 314篇 |
基础医学 | 1782篇 |
口腔科学 | 275篇 |
临床医学 | 1449篇 |
内科学 | 2233篇 |
皮肤病学 | 171篇 |
神经病学 | 1194篇 |
特种医学 | 733篇 |
外国民族医学 | 2篇 |
外科学 | 1696篇 |
综合类 | 224篇 |
一般理论 | 6篇 |
预防医学 | 1255篇 |
眼科学 | 202篇 |
药学 | 837篇 |
中国医学 | 16篇 |
肿瘤学 | 899篇 |
出版年
2022年 | 88篇 |
2021年 | 182篇 |
2020年 | 99篇 |
2019年 | 164篇 |
2018年 | 195篇 |
2017年 | 153篇 |
2016年 | 172篇 |
2015年 | 226篇 |
2014年 | 288篇 |
2013年 | 411篇 |
2012年 | 569篇 |
2011年 | 555篇 |
2010年 | 292篇 |
2009年 | 319篇 |
2008年 | 533篇 |
2007年 | 536篇 |
2006年 | 520篇 |
2005年 | 546篇 |
2004年 | 479篇 |
2003年 | 444篇 |
2002年 | 404篇 |
2001年 | 367篇 |
2000年 | 406篇 |
1999年 | 351篇 |
1998年 | 210篇 |
1997年 | 213篇 |
1996年 | 213篇 |
1995年 | 157篇 |
1994年 | 163篇 |
1993年 | 147篇 |
1992年 | 265篇 |
1991年 | 255篇 |
1990年 | 275篇 |
1989年 | 295篇 |
1988年 | 259篇 |
1987年 | 261篇 |
1986年 | 232篇 |
1985年 | 260篇 |
1984年 | 186篇 |
1983年 | 151篇 |
1982年 | 141篇 |
1981年 | 115篇 |
1980年 | 119篇 |
1979年 | 152篇 |
1978年 | 132篇 |
1977年 | 111篇 |
1976年 | 119篇 |
1975年 | 88篇 |
1974年 | 102篇 |
1973年 | 108篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
Neal R. Barshes Timothy C. Lee Ian W. Udell Christine A. O'Mahoney Beth A. Carter Saul J. Karpen John A. Goss 《American journal of transplantation》2005,5(8):2047-2051
Split liver transplantation (SLT) benefits society by increasing the total number of transplants that can be performed, but it is yet unknown if a decreased post-transplant survival (in comparison to whole liver transplantation) would make participation in SLT less appealing to adult liver transplant candidates. A 20-item questionnaire was administered to 50 adult candidates to assess attitudes toward SLT and organ sharing. The overall attitudes of 60% of participants were classified as utilitarian (maximizing benefit to greatest number of candidates), while 26% were classified as self-preserving (maximizing individual benefit) and 14% were undecided. Ninety percent of participants would be willing to share even if expected survival was less than that of whole liver transplantation, and 69% felt that pediatric candidates should have priority over adult candidates. In conclusion, attitudes toward graft sharing and the possibility of compromised survival benefit are not barriers to SLT for most adult liver transplant candidates. 相似文献
23.
Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. 总被引:3,自引:0,他引:3
Robertson Parkman Geoff Cohen Shelly L Carter Kenneth I Weinberg Bernadette Masinsin Eva Guinan Joanne Kurtzberg John E Wagner Nancy A Kernan 《Biology of blood and marrow transplantation》2006,12(9):919-927
Allogeneic hematopoietic stem cell transplantation (HSCT) is established therapy for selected patients with acute leukemia. After transplantation, antileukemic immune responses are believed to eliminate residual leukemia cells and decrease the likelihood of relapse. However, the clinical effect of successful antigen-specific immune reconstitution after HSCT on the likelihood of leukemic relapse and overall survival is not known. Pediatric recipients of unrelated cord blood transplants who underwent transplantation for acute leukemia were sequentially evaluated for their development of antigen-specific T-lymphocyte immunity to herpes viruses. The clinical effect of a positive antigen-specific response on relapse-free survival was determined. The presence of an antigen-specific response resulted in a relapse-free survival advantage (P = .0001), which was primarily due to a decrease in leukemic relapse (P = .003). Proportional hazards modeling for time to relapse and time to relapse or death defined 3 variables that were strongly associated with a poor outcome: female gender, poor remission status before transplantation, and negative antigen-specific T-lymphocyte proliferation. Notably neither acute nor chronic graft-versus-host disease had any effect on the incidence of leukemic relapse. Successful antigen-specific immune reconstitution after unrelated cord blood transplantation results in decreased leukemic relapse and improved overall survival. 相似文献
24.
25.
26.
Dr. Mark C. Granberry Pharm.D. Dr. Stephanie F. Gardner Pharm.D. Dr. Eric F. Schneider Pharm.D. Dr. Inge R. Carter M.D. 《Pharmacotherapy》1996,16(5):932-936
Study Objective . To determine if one commercial extended-release formulation of nifedipine (Adalat CC) is as effective as another (Procardia XL) in controlling blood pressure over 24 hours. Design . Open-label, randomized, crossover study. Setting . University-affiliated family medicine clinic. Patients . Fifteen patients with stage 1–4 primary hypertension. Interventions . Procardia XL or Adalat CC once/day was titrated to achieve blood pressure control. The effective dose was continued for 4 weeks, washed out for 1 week, and reinstituted with other study drug. Measurements and Main Results . Twenty-four-hour ambulatory blood pressure was recorded the conclusion of each treatment phase. Treatment phases were compared for mean 24-hour blood pressure, mean daytime (6:00 a.m.–10:00 p.m.) and mean nighttime blood pressure, and mean blood pressure load (percentage of blood pressure measurements < 140/90 mm Hg daytime and > 120/80 mm Hg nighttime). Thirteen patients completed the study. No statistically significant difference was seen in mean 24-hour blood pressure (138/86 mm Hg for Procardia XL vs 137/85 mm Hg for Adalat CC), daytime or nighttime blood pressure, or blood pressure load. Two patients experienced clinically significant adverse effects while taking Adalat CC. Conclusions . In these patients with primary hypertension, Adalat CC was as effective as Procardia XL at controlling blood pressure for 24 hours. Blood pressure, heart rate, and adverse effects should be monitored 2–4 weeks after any exchange of Adalat CC for Procardia XL. 相似文献
27.
28.
Martin E. Weinand Bruce Hermann Allen R. Wyler L. Philip Carter K. J. Oommen David Labiner Geoff Ahern Anne Herring 《Epilepsia》1994,35(5):1054-1059
Summary: We report a series of 8 patients with ictal déjà vu. Subdural strip electrocorticographic (ECoG) monitoring localized the ictal epileptogenic focus as follows: right (n = 6) and left (n = 2) mesiotemporal lobe. In all 8 patients, the left hemisphere was dominant for language function based on intracarotid amytal testing. In 6 right-handed patients, ictal déjà vu was associated with a right temporal lobe focus. However, in the 2 left-handed patients, the ictal focus was left temporal lobe. Although ictal déjà vu localizes the epileptic focus to temporal lobe, this experiential phenomenon appears to lateralize to the hemisphere nondominant for handedness. 相似文献
29.
30.